 |
|
Differential Response to Chlorpromazine, Imipramine, and PlaceboA Study of Subgroups of Hospitalized Depressed Patients
Allen Raskin, PhD;
Joy G Schulterbrandt, MS;
Natalie Reatig, BA;
Chevy Chase, Md;
James J McKeon, PhD
Arch Gen Psychiatry. 1970;23(2):164-173.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
A MAJOR aim of the present study was to examine the differential effects of chlorpromazine and imipramine among various depression subgroups. Tests were made of differential drug effects among Overall et al's1 three empirically derived depressive subtypes, ie, anxious, hostile, and withdrawn-retarded depressives. These investigators found a tranquilizer, thioridazine, best for their anxious depressives and imipramine best for the withdrawn-retarded depressives. An examination was also made of differential drug effects among psychotic depressives, neurotic depressives, and schizophrenics with depression. As there is a tendency in this country to equate psychotic depression with endogenous depression, study findings may have some relevance for the endogenous-neurotic distinction. Proponents of this distinction have reported that imipramine is especially efficacious for endogenous depression and of little value in neurotic depressions.2-12
Finally, tests were made of differential drug effects among depressed patients categorized on the basis of sex and age (below 40 and 40 and
. . . [Full Text PDF of this Article]
Author Affiliations
Washington. DC
From the National Institute of Mental Health, Psychopharmacology Research Branch, Collaborative Depression Study Group, Chevy Chase, Md.
Footnotes
Submitted for publication June 5, 1969.
Reprint requests to Psychopharmacology Research Branch, NIMH, Barlow Bldg, Room 10D-06, 5454 Wisconsin Ave, Chevy Chase, Md 20015 (Dr. Raskin).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
